Europe approves Allied Healthcare's regenerative product

08/26/2013 | BioSpectrum Asia

Allied Healthcare has earned the CE mark to market CardioCel, the company's lead regenerative product, in Europe. The device is used for the repair of cardiac defects, including those related to heart valves and congenital heart disease in adults and children.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ